Chemotherapy Duration for Various Indications in Colorectal Cancer: a Review-Reference-Cited by-同舟云学术

Chemotherapy Duration for Various Indications in Colorectal Cancer: a Review

Published:2023-02-13 Issue:4 Volume:25 Page:341-352
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Damato Angela,Ghidini Michele,Dottorini Lorenzo,Tomasello Gianluca,Iaculli Alessandro,Ghidini Antonio,Luciani Andrea,Petrelli Fausto^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11912-023-01378-5.pdf

Reference75 articles.

1. Saltz LB, Clarke S, Díaz-Rubio E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study. J Clin Oncol. 2008. https://doi.org/10.1200/JCO.2007.14.9930.

2. •• André T, Meyerhardt J, Iveson T, Sobrero A, Yoshino T, Souglakos I, Grothey A, Niedzwiecki D, Saunders M, Labianca R, Yamanaka T, Boukovinas I, Vernerey D, Meyers J, Harkin A, Torri V, Oki E, Georgoulias V, Taieb J, Shields A, Shi Q. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. Lancet Oncol. 2020;21(12):1620–1629. https://doi.org/10.1016/S1470-2045(20)30527-1. Pooled analysis of studies comparing different adjuvant chemotherapy duration in colon cancer.

3. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349(3):247–57.

4. Network NCC. NCCN Clinical Practice Guidelines in Oncology, colon cancer 2021. Available from: https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Accessed 8 Feb 2022

5. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343–51.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selumetinib overcomes ITGA2-induced 5-fluorouracil resistance in colorectal cancer;International Immunopharmacology;2024-08

2. Integrated single-cell and bulk RNA sequencing revealed an epigenetic signature predicts prognosis and tumor microenvironment colorectal cancer heterogeneity;World Journal of Gastrointestinal Oncology;2024-07-15

3. Characterization and efficacy of C60 nano-photosensitive drugs in colorectal cancer treatment;Biomedicine & Pharmacotherapy;2024-07

4. Upregulated lncRNA PRNT promotes progression and oxaliplatin resistance of colorectal cancer cells by regulating HIPK2 transcription;World Journal of Gastrointestinal Oncology;2024-04-15

5. Synthesis, Pharmacological Properties, and Potential Molecular Mechanisms of Antitumor Activity of Betulin and Its Derivatives in Gastrointestinal Cancers;Pharmaceutics;2023-12-13